Pacific Edge still spending, but US diagnostics up

Pacific Edge still spending, but US diagnostics up
Brent Melville
The cash burn continues at Pacific Edge, with a total of $14.8 million in cash in the bank at end of March, following $20.1 million of new capital raised just five months ago. Reporting a net loss of $18.9 million for the 12 months ended March 31, the Dunedin-based cancer diagnostics company said while operating revenues from test sales were up 14 percent at $4.4 million, operating expenses had also increased 5 percent to $24.1 million. This was primarily due to the impact of the weaker kiwi dollar. Cash receipts from customers improved b...

More Listed Companies

Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024
Market watchdog puts Fletcher result under microscope
Markets

Market watchdog puts Fletcher result under microscope

Listed firms sitting on material information a theme of NZ RegCo oversight report.

How Gentrack made its India expansion work
Markets

How Gentrack made its India expansion work

Gentrack has more than 100 staff in Pune, India.

NZME boss calls for digital platform law
Listed Companies

NZME boss calls for digital platform law

NZME CEO Michael Boggs calls for government solution to big tech bargaining imbalance.

Daniel Dunkley 21 Feb 2024